| This week's sponsor is Ajinomoto Bio-Pharma Services. | |  | |
Today's Rundown Featured Story | | | Monday, March 11, 2019 Axovant has a pair of clinical readouts from its switch into gene therapy after failed endeavors in Alzheimer’s disease—and the initial data look encouraging. |
|
|
Top Stories Monday, March 11, 2019 Snipr Biome has raised $50 million to take CRISPR-based microbiome drugs into clinical trials. The Danish biotech is using CRISPR/Cas to selectively target and kill bacteria with specific DNA sequences. Monday, March 11, 2019 The submission comes a year after Celgene received an embarrassing refuse-to-file letter for ozanimod from the FDA after the agency determined that the nonclinical and clinical pharmacology information provided were insufficient. Monday, March 11, 2019 Strengthen Your Protocol With Patient Insights. See how Covance helps sponsors reduce patient burden to increase participation and improve patient retention. Monday, March 11, 2019 Stemline Therapeutics has licensed the global rights to a preclinical RET inhibitor. The drug, SL-1001, was designed to improve outcomes in RET-dependent tumors by selectively hitting the target. Monday, March 11, 2019 A buildup of the protein amyloid-beta in spinal fluid can predict Alzheimer's long before symptoms appear, but it's difficult to detect. IBM researchers have identified four proteins that can be found in blood and can predict amyloid-beta buildup with up to 77% accuracy. Resources Sponsored by: Patheon, part of Thermo Fisher Scientific The Right Partner Can Improve Flexibility and Mitigate Risks from Forecast Inaccuracy in Biomanufacturing. Sponsored by: Patheon, part of Thermo Fisher Scientific Download this whitepaper to learn more. Sponsored by: ON24 Which HCP Touchpoints and channels are yielding the best results in today’s digital world? Sponsored by: Blue Matter White paper outlining the key types of cell-based immunotherapies in oncology, as well as the development and commercial outlook for each. Sponsored by: AlphaSense It’s never been more challenging to stay on top of trends and innovation shaping the future of healthcare. Discover how AI can help competitive intelligence teams achieve more proactive strategies. Sponsored by: Outer Edge Technology With FDA approval imminent, start-up Life Sciences company partners with an industry focused MSP to design and manage its regulated cloud-based infrastructure to speed time to market. Presented by: Veeva Share your thoughts on the life sciences industry's progress in improving study execution. Sponsored by: Biotech Primer The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry. | 
.jpg/Pavan%20headshot%20(1).jpg/caacc324d6331e0cb621e889cc14c1ae)
